What are the indications for continuous glucose monitoring (CGM) in patients with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indications for Continuous Glucose Monitoring (CGM)

CGM is primarily indicated for all patients with type 1 diabetes on intensive insulin therapy (multiple daily injections or insulin pump), and for type 2 diabetes patients on intensive insulin regimens who experience problematic hypoglycemia or significant glycemic variability. 1, 2

Primary Indications by Patient Population

Type 1 Diabetes (Strongest Evidence)

All patients with type 1 diabetes should be offered CGM regardless of their current HbA1c level, as this represents the highest quality evidence for benefit 2, 3:

  • Children and adolescents with type 1 diabetes - CGM should be considered in all pediatric patients, whether using injections or insulin pumps, as benefits correlate with adherence to ongoing device use 4
  • Adults with type 1 diabetes capable of using CGM daily 1
  • Patients with HbA1c <7% - CGM helps maintain excellent control without increasing hypoglycemia risk 1
  • Patients with HbA1c ≥7% who can commit to near-daily use 1

Type 2 Diabetes (Expanding Indications)

For type 2 diabetes, CGM is indicated when patients meet ANY of the following criteria 1:

  1. Intensive insulin therapy (≥3 injections daily or insulin pump use)
  2. Problematic hypoglycemia:
    • Unexplained severe or recurrent hypoglycemia
    • Asymptomatic hypoglycemia (hypoglycemia unawareness)
    • Nocturnal hypoglycemia
    • Patients maintaining artificially high glucose levels due to fear of hypoglycemia
  3. Unexplained hyperglycemia, particularly fasting hyperglycemia
  4. Dramatic glycemic variability despite therapy adjustments
  5. HbA1c above target despite multiple oral agents and/or non-insulin injectables
  6. Hospitalized patients on insulin therapy in non-ICU settings (reduces glucose fluctuations and achieves targets without increasing hypoglycemia) 1
  7. Perioperative glycemic control 1

Pregnancy-Related Diabetes

CGM should be used in pregnant women with type 1 diabetes as it improves A1C, time in range, and neonatal outcomes 4, 3. It may also benefit patients with gestational diabetes and women with pre-existing type 2 diabetes during pregnancy 1.

Special Clinical Situations

CGM is indicated for 1:

  • Diabetes with gastroparesis
  • Special types of diabetes with dramatic glycemic variability
  • Endocrine disorders accompanied by significant glucose fluctuations
  • Diabetes education purposes - helps patients understand glucose responses to diet, exercise, stress, sleep, and medications

Real-Time vs. Retrospective CGM Selection

Real-Time CGM is preferred for:

  • All type 1 diabetes patients capable of daily use 1
  • Type 2 diabetes patients at high risk for hypoglycemia on insulin or sulfonylureas 2
  • Pregnant women with type 1 diabetes 4
  • Patients requiring immediate glucose trend information and alerts

Retrospective (Professional) CGM is appropriate for:

  • Initial assessment of glycemic patterns
  • Patients unable to commit to daily real-time CGM use
  • Periodic evaluation when continuous use is not feasible 3

Important Contraindications and Precautions

CGM should NOT be used in the following settings 1:

  • Intensive care units - interstitial fluid glucose may be inaccurate due to:
    • Skin edema (dilutes interstitial glucose)
    • Vasopressor use (decreases skin blood flow)
    • Hypotension or hypoxemia
    • High-dose acetaminophen

CGM is NOT suitable for patients who 1:

  • Are unwilling to learn basic device operation
  • Cannot commit to ongoing education and device maintenance
  • Have unrealistic expectations about device capabilities

Critical Implementation Requirements

For CGM to be successful, the following MUST be in place 5, 4, 5:

  1. Robust diabetes education and training before initiation
  2. Ongoing support for device troubleshooting and data interpretation
  3. Access to fingerstick blood glucose monitoring for calibration (some devices) and confirmation when symptoms don't match sensor readings 2, 4
  4. Patient commitment to near-daily use for real-time systems or frequent scanning (minimum every 8 hours) for intermittently scanned systems 4
  5. Regular follow-up to review data and adjust therapy

Key Clinical Pearls

  • Frequency matters: Real-time CGM should be used as close to daily as possible for maximal benefit 4
  • Education is non-negotiable: Comprehensive training on device use, data interpretation, and troubleshooting is critically important for success 2, 4
  • Assess readiness: Evaluate individual readiness and motivation before prescribing, as adherence is variable 5
  • Avoid MRI exposure: Patients must avoid strong magnetic fields, MRI, and in some cases CT/X-ray depending on device 1
  • Monitor for skin reactions: Address irritation or allergic reactions promptly to maintain adherence 3
  • Inpatient continuation: Patients already using personal CGM should continue it during hospitalization when possible 2

References

1
Guideline

chinese clinical guidelines for continuous glucose monitoring (2018 edition).

Diabetes/Metabolism Research and Reviews, 2019

Related Questions

Is it acceptable to substitute a 100 g package of glucose powder by measuring out 50 g to replace a prescribed 50 g dose?
What should a 61-year-old woman with diabetes do when she develops severe hyperglycemia after starting prednisone 10 mg twice daily for sciatica?
Can uncontrolled hypertension be an underlying cause of the diabetic patient's complications due to poor adherence to antihypertensive medication?
How should I manage a 71-year-old male with diabetes mellitus, hypertension, and hyperlipidemia who presents with chest pain, a normal stress test, and sinus rhythm on electrocardiogram?
In a female patient with years of postprandial hypoglycemia (glucose 3.9–2.1 mmol/L) treated with diazoxide, are her fatigue, migraines, muscle aches, and mood swings caused by the hypoglycemia or the medication?
What are the causes of aortic regurgitation and pulmonary regurgitation?
Is severe acute cholangitis managed in the intensive care unit?
Is a nine‑day delay in my period normal after taking emergency contraception (levonorgestrel or ulipristal acetate)?
What is the recommended treatment for low‑grade appendiceal mucinous neoplasm (LAMN) based on tumor size and high‑risk features?
What pharmacologic options are recommended for an adult with inhalant (air‑duster) dependence experiencing cravings?
What should I do if lactase enzyme supplements are not effective?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question